Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 9, 2016
August 02 2016 - 4:05PM
GAITHERSBURG, Md., Aug. 02, 2016
(GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage
vaccine company focused on the discovery, development and
commercialization of recombinant nanoparticle vaccines and
adjuvants, today announced it will report its second quarter 2016
financial and operating results after the close of U.S. financial
markets on Tuesday, August 9, 2016.
Management will host a conference
call to discuss the quarterly financial results and provide an
update on corporate activities.
Conference call details are as follows:
| Date: |
|
Tuesday, August 9,
2016 |
| Time: |
|
4:30 p.m. U.S. Eastern
Time (ET) |
| Dial-in number: |
|
(877) 212-6076
(Domestic) or (707) 287-9331 (International) |
| Passcode: |
|
59901631 |
| Via web: |
|
www.novavax.com,
"Investors"/ "Events" |
| |
|
|
Conference call replay:
| Date: |
|
Starting at 7:30 p.m.
ET, August 9, 2016 until August 16, 2016 |
| Dial-in number: |
|
(855) 859-2056
(Domestic) or (404) 537-3406 (International) |
| Passcode: |
|
59901631 |
| Via web: |
|
www.novavax.com,
"Investors"/ "Events" |
| |
|
|
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a
clinical-stage vaccine company committed to delivering novel
products to prevent a broad range of infectious diseases. Its
recombinant nanoparticles and Matrix-M(TM) adjuvant technology are
the foundation for groundbreaking innovation that improves global
health through safe and effective vaccines.
Contact:
Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir@novavax.com
240-268-2000
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Novavax, Inc. via Globenewswire
HUG#2032723
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024
